TH43442A - Nicotine amide derivatives - Google Patents
Nicotine amide derivativesInfo
- Publication number
- TH43442A TH43442A TH9801001010A TH9801001010A TH43442A TH 43442 A TH43442 A TH 43442A TH 9801001010 A TH9801001010 A TH 9801001010A TH 9801001010 A TH9801001010 A TH 9801001010A TH 43442 A TH43442 A TH 43442A
- Authority
- TH
- Thailand
- Prior art keywords
- disease
- weight control
- body weight
- respiratory
- rheumatoid
- Prior art date
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical class NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 abstract 4
- 238000004260 weight control Methods 0.000 abstract 4
- 208000035473 Communicable disease Diseases 0.000 abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract 3
- 230000037396 body weight Effects 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 206010009944 Colon cancer Diseases 0.000 abstract 2
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 2
- 208000002720 Malnutrition Diseases 0.000 abstract 2
- 230000005856 abnormality Effects 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 230000007815 allergy Effects 0.000 abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 208000010668 atopic eczema Diseases 0.000 abstract 2
- 208000029742 colonic neoplasm Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 210000004072 lung Anatomy 0.000 abstract 2
- 230000001071 malnutrition Effects 0.000 abstract 2
- 235000000824 malnutrition Nutrition 0.000 abstract 2
- 201000009240 nasopharyngitis Diseases 0.000 abstract 2
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract 2
- 210000002345 respiratory system Anatomy 0.000 abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 2
- 230000035939 shock Effects 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 229940124321 AIDS medicine Drugs 0.000 abstract 1
- 208000014912 Central Nervous System Infections Diseases 0.000 abstract 1
- 206010054089 Depressive symptom Diseases 0.000 abstract 1
- 208000025222 central nervous system infectious disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000002644 respiratory therapy Methods 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Abstract
DC60 (18/06/41) สารประกอบตามสูตร (สูตรเคมี) I โดย m,n,o,p,q,r,A,B,D,E,R1,R2,R3,R4,R5,R6,R7,R8 เป็นตาม กำหนดข้างต้น, โดยใช้ประโยชน์ในการรักษาระบบทางเดินหายใจ, ภูมิแพ้, รูมาตอยด์, ควบคุมน้ำหนักตัว, โรคติดเชื้อระบบประสาทส่วนกลาง เช่น หอบหืด, โรคปอดเรื้อรัง, โรคทางเดินหายใจในผู้ใหญ่, ช็อค, การเกิดเนื้อเยื่อผิดปกติ, ปอดไวต่อสิ่งกระตุ้น, เยื่อ เมือกช่องจมูกอักเสบ, ผิวหนังอักเสบเฉพาะที่, เรื้อนกวาง, ภาวะขาดอาหาร, ควบคุม น้ำหนักตัว, ข้ออักเสบรูมาตอยด์, โรคโครน, มะเร็งลำไส้ใหญ่, โรคติดเชื้ออื่น, อาการ หดหู่, โรคจิตเสื่อม และ AIDS สารประกอบตามสูตร(สูตรเคมี) โดย m,n,o,p,q,r,A,B,D,E,R1,R2,R3,R4,R5,R6,R7,R8 เป็นตาม กำหนดข้างต้น, โดยใช้ประโยชน์ในการรักษาระบบทางเดินหายใจ, ภูมิแพ้ รูมารตอยด์, ควบคุมน้ำหนักตัว, โรคติดเชื้อระบบ ประสาทส่วนกลาง เช่น หอบหืด, โรคปอดเรื้อรัง, โรงทางเดิน หายใจผู้ใหญ่, ช็อค, การเกิดเนื้อเยื่อผิดปกติ, ปอดไวต่อ สิ่งกระตุ้น, เยื่อเมือกช่องจมูกอักเสบ, ผิวหนังอักเสบ เฉพาะที่, เรื้อนกวาง, ภาวะขาดอาหาร, ควบคุมน้ำหนักตัว, ข้ออักเสบรูมาตอยด์, โรคโครน, มะเร็งลำไส้ใหญ่, โรคติด เชื้ออื่น, อาการหดหู่, โรคจิตเสื่อม และ AIDS สิทธิบัตรยา DC60 (18/06/41) compound according to the formula (chemical formula) I by m, n, o, p, q, r, A, B, D, E, R1, R2, R3, R4, R5, R6, R7, R8 as prescribed above, is utilized in the treatment of respiratory system, allergies, rheumatoid, body weight control, central nervous system infections such as asthma, cystic fibrosis, respiratory disease in adults, Shock, tissue abnormalities, sensitive lungs, mucous membranes, nasopharyngitis, local dermatitis, eczema, malnutrition, weight control, rheumatoid arthritis, krone disease, colon cancer. , Other infectious diseases, depressive symptoms, dementia and AIDS compound formulated (chemical formula) by m, n, o, p, q, r, A, B, D, E, R1, R2, R3, R4, R5, R6, R7, R8 as prescribed above, are utilized in respiratory therapy, rheumatoid allergy, body weight control, systemic infectious disease. Central nervous disorders such as asthma, cystic fibrosis, adult respiratory tract, shock, tissue abnormalities, hypersensitivity lungs, nasopharyngitis, local dermatitis, eczema, malnutrition, body weight control. , Rheumatoid arthritis, Krone disease, colon cancer, other infectious diseases, depression, dementia and AIDS drug patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH43442A true TH43442A (en) | 2001-03-02 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA85708C2 (en) | Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases | |
| MXPA04005444A (en) | Ureas of 2-aminobenzothiazoles as adenosine modulators. | |
| US20070287700A1 (en) | Polycyclic agents for the treatment of respiratory syncytial virus infections | |
| MY148145A (en) | Methods of synthesis and/or purification of diaminophenothiazinium compounds | |
| DE60108724D1 (en) | NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS, AND INTERMEDIATES FOR EACH MANUFACTURE | |
| CA2401229A1 (en) | Aryl fused azapolycyclic compounds | |
| EP1541563A4 (en) | Ccr4 antagonist and medicinal use thereof | |
| CA2564201A1 (en) | Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands | |
| DE69834430D1 (en) | PURIN DERIVATIVES FOR THE TREATMENT OF ALLGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATODES | |
| WO2003000241A3 (en) | Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases | |
| SE0104340D0 (en) | New compounds | |
| PL341291A1 (en) | 1-substituted derivatives of 1-aminomethyl-ccycloalkanes (gabapentin analogues), their production and application of them in treating neurological disorders | |
| DK0647219T3 (en) | Vitamin D series derivatives modified at the 20-position, process for the preparation of such derivatives, intermediates for use in the process, pharmaceutical compositions containing the derivatives and their use in the manufacture of drugs | |
| AU2001277751A1 (en) | Novel 3-substituted urea derivatives and medicinal use thereof | |
| WO2005111002A3 (en) | Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases | |
| NO20071967L (en) | Imidazo-benzodiazepine | |
| MXPA05009574A (en) | Substituted 8'-pyridinyl -dihydrospiro -[cycloalkyl]- pyrimido [1, 2-a] pyrimidin-6 -one and 8'-pyrimidinyl -dihydrospiro -[cycloalkyl]- pyrimido [1, 2-a] pyrimidin-6- one derivatives and their use against neurogenerative diseases. | |
| ATE367387T1 (en) | USE OF OXINDOL DERIVATIVES FOR THE TREATMENT OF DEMENTIA-RELATED DISEASES, ALZHEIMER'S DISEASE AND GLYCOGEN SYNTHASE KINASE-3-ASSOCIATED CONDITIONS | |
| MXPA06013221A (en) | Inhalation powder formulations containing enantiomerically pure beta-agonists. | |
| TH43442A (en) | Nicotine amide derivatives | |
| HUP0302616A2 (en) | Dervatives of tryptamine and analogous their use, and pharmaceutical compositions containing them | |
| SG137859A1 (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| MXPA04000007A (en) | Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction. | |
| RU2008110945A (en) | N-OXIDES AS MEDICINES OF PIPERASIN AND PIPERIDINE DERIVATIVES | |
| HUP0400877A2 (en) | Use of substituted imidazol[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases and process for preparing them |